Method for producing interleukin-2 protein using methylotrophic yeast

US2018237488A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2018237488-A1
Application numberUS-201515523290-A
CountryUS
Kind codeA1
Filing dateMay 13, 2015
Priority dateOct 30, 2014
Publication dateAug 23, 2018
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a method for producing an interleukin-2 protein using methylotrophic yeast. The method for producing interleukin-2 according to the present invention shows high cell growth and protein synthesis rates by use of the established optimal cell line, and produces a large amount of a protein comprising interleukin-2 by use of the established optimal culture conditions utilizing methanol that is an inexpensive carbon source. In addition, the method according to the present invention isolates and purifies the protein by a simple process. Accordingly, the method according to the present invention highly pure interleukin-2, and thus has a significant effect on the mass-production of interleukin-2.

First claim

Opening claim text (preview).

1 . A method for producing interleukin-2, comprising the steps of: (a) cloning an interleukin-2 expression construct for yeast, wherein the expression construct comprises a methanol oxidase (MOX) promoter, a human serum albumin gene or a fragment thereof, and an interleukin-2 gene; (b) transforming yeast host cells with the expression construct prepared in step (a), and culturing the transformed yeast cells to express interleukin-2; and (c) isolating the expressed interleukin-2 from the transformed yeast cells cultured in step (b). 2 . The method of claim 1 , wherein the expression construct in step (a) further comprises a tobacco etch virus protease site. 3 . The method of claim 1 , wherein the yeast host in step (b) is any one selected from among Hansenula polymorpha, Pichia pastoris, Candia boidini, Pichia methanolica , and Ogataea minuta. 4 . The method of claim 1 , wherein the culturing in step (b) is performed in YPM (2% (w/v) bacto-peptone, 1% (w/v) bacto-yeast extract, 3% (w/v) methanol) medium. 5 . The method of claim 4 , wherein the culturing in step (b) is performed under the following conditions: a methanol concentration of 1% (w/v) to 10% (w/v), a culture temperature of 25° C. to 45° C., a culture pH of 4.5 to 7.0, and a shaking speed of 100 to 300 rpm. 6 . The method of claim 1 , wherein the methanol oxidase (MOX) promoter has a nucleotide sequence of SEQ ID NO:1; the human serum albumin gene or the fragment thereof has a nucleotide sequence of SEQ ID NO:2 or SEQ ID NO:3; and the interleukin-2 gene has a nucleotide sequence of SEQ ID NO:4. 7 . A method for producing interleukin-2, comprising the steps of: (a) culturing Hansenula polymorpha transformed with an interleukin-2 expression construct for yeast, wherein the expression construct comprises a methanol oxidase (MOX) promoter, a human serum albumin gene or a fragment thereof, a tobacco etch virus protease site, and an interleukin-2 gene; (b) isolating a protein from the culture of step (a); and (c) treating the isolated protein of step (b) with tobacco etch virus protease to separate interleukin-2. 8 . The method of claim 7 , wherein the transformed Hansenula polymorpha in step (a) is a strain deposited under accession number Hansenula polymorpha KCTC18329P. 9 . The method of claim 7 , wherein the culturing in step (a) is performed in YPM (2% (w/v) bacto-peptone, 1% (w/v) bacto-yeast extract, 3% (w/v) methanol) medium. 10 . The method of claim 9 , wherein the culturing in step (a) is performed under the following conditions: a methanol concentration of 1% (w/v) to 10% (w/v), a culture temperature of 25° C. to 45° C., a culture pH of 4.5 to 7.0, and a shaking speed of 100 to 300 rpm. 11 . The method of claim 7 , wherein the treating with the tobacco etch virus protease is performed at a temperature of 28° C. to 32° C. for 4 to 8 hours.

Assignees

Inventors

Classifications

  • Serum albumin, e.g. HSA · CPC title

  • C12N15/81Primary

    for yeasts · CPC title

  • C07K14/55Primary

    IL-2 · CPC title

  • having a known sequence of two or more amino acids, e.g. glutathione · CPC title

  • containing protease site · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2018237488A1 cover?
The present invention relates to a method for producing an interleukin-2 protein using methylotrophic yeast. The method for producing interleukin-2 according to the present invention shows high cell growth and protein synthesis rates by use of the established optimal cell line, and produces a large amount of a protein comprising interleukin-2 by use of the established optimal culture conditions…
Who is the assignee on this patent?
Univ Soonchunhyang Ind Acad Coop Found
What technology area does this patent fall under?
Primary CPC classification C12N15/81. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Aug 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).